| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/22/2006 | US7094881 For diagnosis and therapy |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094875 With advantages such as ability of the polypeptides to preferentially bind a CD28/CTLA-4 receptor at a level greater or less than the ability of human B7-1, inhibit altered level of T cell proliferation response greater than human B7-1 |
| 08/22/2006 | US7094868 Peptides for recognition and targeting of GLIAL cell tumors |
| 08/22/2006 | US7094600 Screen for sodium channel modulators |
| 08/22/2006 | US7094598 gene expression vectors comprising enhancers having sequence identity to dna sequences, that elicit immune responses against viral disease |
| 08/22/2006 | US7094589 53010, A novel human carboxylesterase family member and uses thereof |
| 08/22/2006 | US7094585 genetic engineered nucleotide sequences that code polypeptides used as biosensors for measurement of glucose using enzyme electrodes |
| 08/22/2006 | US7094579 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm |
| 08/22/2006 | US7094578 α1,2 fucosyltransferase |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094576 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 08/22/2006 | US7094574 Recombinant cell clones having increased stability and methods of making and using the same |
| 08/22/2006 | US7094573 ribosome binding site sequences, genetic vectors containing such sequences, and host cells transformed with these vectors, used for biosynthesis proteins and fragments in prokaryotic cells |
| 08/22/2006 | US7094571 Combinatorial protein library screening by periplasmic expression |
| 08/22/2006 | US7094570 Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 08/22/2006 | US7094569 Polypeptide for use in the treatment and prevention of alopecia |
| 08/22/2006 | US7094568 Generation of preferential proteins; provide nucleotide sequences, amplify, incubate nucleotide sequences with nuclease, clone sequences into expression vector, express coded proteins, recover proteins |
| 08/22/2006 | US7094567 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2006 | US7094566 IL-17 receptor like molecules and uses thereof |
| 08/22/2006 | US7094565 polynucleotides that code polypeptides having oxidoreductase or alcohol dehydrogenase activity, used for drug screening, diagnosis and prophylaxis of brain, gastrointerstinal or urogenital disorders |
| 08/22/2006 | US7094564 polynucleotides that code for lymphotoxin polypeptide receptors, used for screening antagonists and/or agonists to the receptors; genetic engineering |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/22/2006 | US7094548 Polypeptide for use in purifying and separation of target peptides |
| 08/22/2006 | US7094547 Sperm specific proteins |
| 08/22/2006 | US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide |
| 08/22/2006 | US7094403 Mycobacterium tuberculosis superoxide dismutase |
| 08/22/2006 | US7094398 double-stranded vector carries transgenes for stable and efficient gene transfer into diverse cell types or tissues in a CAR- and/or alpha upsilon beta 3/5-independent manner; gene therapy; tissue-targeted therapy |
| 08/22/2006 | US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy |
| 08/22/2006 | CA2044468C Canine granulocyte macrophage colony stimulating factor |
| 08/17/2006 | WO2006086799A2 Prion-specific peptide reagents |
| 08/17/2006 | WO2006086607A2 Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation |
| 08/17/2006 | WO2006086326A2 Biological production of clavulanic acid and related compounds |
| 08/17/2006 | WO2006085938A2 Il-13 binding agents |
| 08/17/2006 | WO2006085553A1 Anti-tlr6 antibody and utilization of the same |
| 08/17/2006 | WO2006085518A1 Method for improving antibody |
| 08/17/2006 | WO2006084826A1 Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
| 08/17/2006 | WO2006084388A1 Monomeric streptavidin muteins |
| 08/17/2006 | WO2006084383A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | WO2006053656A3 Method for production of a heterologous protein using yeast-type host cells |
| 08/17/2006 | WO2006039135A3 Irta-4 antibodies and their uses |
| 08/17/2006 | WO2006026331A3 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 08/17/2006 | WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/17/2006 | WO2005065239A8 Novel recombinant proteins with n-terminal free thiol |
| 08/17/2006 | WO2004110359A3 Fusion proteins for the treatment of cns |
| 08/17/2006 | WO2004067553A3 Tolerance-induced targeted antibody production |
| 08/17/2006 | WO2003104391A3 Antibacterial targets in alloiococcus otitidis |
| 08/17/2006 | US20060183688 Screening for drugs for treatment of pathologies involving deregulation of apoptosis including autoimmune diseases, neurological disorders and cancers |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183686 Thrombin-activatable fibrinolysis inhibitors (TAFI) enzyme molecules; inhibit the breakdown of blood clots, for use in treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease |
| 08/17/2006 | US20060183679 Peptides having a high cysteine content |
| 08/17/2006 | US20060183675 Controlling microorganisms; wound healing products, bandages, medical devices such as, e.g., catheters and further in anti-dandruff hair products |
| 08/17/2006 | US20060183213 Animal feed composition containing a thermotolerant phytase which retains at least 40% activity after 30 minutes at 60 degrees C. and has a specific activity of greater than 200 U/mg at pH 4.5 and 37 degrees C |
| 08/17/2006 | US20060183210 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor |
| 08/17/2006 | US20060183201 Autologous progenitor stem cells of gastrointestinal origin |
| 08/17/2006 | US20060183200 Methods and means relating to protein variants |
| 08/17/2006 | US20060183199 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 08/17/2006 | US20060183198 Methods for expression and purification of recombinant human growth hormone |
| 08/17/2006 | US20060183196 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof |
| 08/17/2006 | US20060183195 Transgenic non-human animals for producing heterologous antibodies |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183193 Vectors and methods for high throughput co-expression |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060183190 Novel transporter protein |
| 08/17/2006 | US20060183189 Regulatable gene expression in mammalian cells and mammals |
| 08/17/2006 | US20060183188 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 08/17/2006 | US20060183187 Gene and polypeptide sequences |
| 08/17/2006 | US20060183186 Gene expression profiles in stomach cancer |
| 08/17/2006 | US20060183162 Novel markers for alternatively activated macrophages |
| 08/17/2006 | US20060183161 IL-ILI gene and polypeptide products |
| 08/17/2006 | US20060183159 Method for engineering a protein by in vitro coevolution |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183134 Nucleotide sequences coding mutY human homologue (MYH) gene for use as diagnostic tool in detection of colon cancer |
| 08/17/2006 | US20060183133 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 08/17/2006 | US20060183131 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/17/2006 | US20060183129 Isolated DNAs encoding the enzyme I-SpomI and its recognition and cutting site; useful in gene mapping and site-directed insertion of genes |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182748 Method of creating antivenom using Emus |
| 08/17/2006 | US20060182740 Buffered formulations for concentrating antibodies and methods of use thereof |
| 08/17/2006 | US20060182736 Transducible dna-binding proteins |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |
| 08/17/2006 | CA2639880A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | CA2597462A1 Novel microbial enzymes and their use |
| 08/17/2006 | CA2596925A1 Method for improving expression level and stability of antibody |
| 08/17/2006 | CA2580882A1 Antibiotic compound |
| 08/17/2006 | CA2570373A1 Il-13 binding agents |
| 08/16/2006 | EP1690945A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 08/16/2006 | EP1690939A2 Novel G protein-coupled receptor proteins |
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |